Home Menu

Site Navigation



NeuroTalk Support Groups > > >

Evaluating Risk versus Benefit of Drugs for MS

 
 
Thread Tools Display Modes
Prev Previous Post   Next Post Next
Old 10-01-2006, 01:54 PM #2
Matt Matt is offline
Junior Member
  
Join Date: Aug 2006
Posts: 23
15 yr Member
Matt Matt is offline
Junior Member
 
Join Date: Aug 2006
Posts: 23
15 yr Member
Default
I see the point you are making, but for any drug that someone takes for a long time for MS, the relative reduction seems relevant. A 33% reduction in relapses means two relapses in three years instead of three relapses in three years...that is if we make the possibly quite incorrect assumption that the drugs have approximately the same effect on everyone who takes it.
Matt is offline   Reply With QuoteReply With Quote
 

« Previous Thread | Next Thread »

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts
BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


All times are GMT -5. The time now is 10:47 PM.


Powered by vBulletin • Copyright ©2000 - 2025, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise (Lite) - vBulletin Mods & Addons Copyright © 2025 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

All posts copyright their original authors.

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.

Always consult your doctor before trying anything you read here.

Home